Enanta Pharmaceuticals
ENTA
$12.92
Share price
-1.75%
Change (1 day)
-64.48%
Change (1 year)
Categories
Operating Margin for Enanta Pharmaceuticals (ENTA)
Operating Margin as of April 2024 (TTM): -158.97%
According to Enanta Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -158.97%. At the end of 2022 the company had an Operating Margin of -141.82%.
Operating Margin history for Enanta Pharmaceuticals from 2012 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -141.82% | 27.97% |
| 2021 | -110.82% | 287.58% |
| 2020 | -28.59% | -228.79% |
| 2019 | 22.20% | -50.74% |
| 2018 | 45.07% | 71.95% |
| 2017 | 26.21% | -28.95% |
| 2016 | 36.89% | -52.7% |
| 2015 | 77.98% | 93.21% |
| 2014 | 40.36% | 34.38% |
| 2013 | 30.03% | -41.46% |
| 2012 | 51.31% | -7.81% |
| 2011 | 55.66% | 63.54% |
| 2010 | 34.03% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -114.39% | 🇺🇸 USA |
 Novartis NVS | 17.27% | -110.86% | 🇨🇭 Switzerland |
 AbbVie ABBV | 18.65% | -111.73% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | 47.39% | -129.81% | 🇺🇸 USA |
 Merck MRK | 27.73% | -117.44% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | -112.10% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.